{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T07:05:57Z","timestamp":1763535957167,"version":"3.44.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.bioorg.2022.105661","type":"journal-article","created":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T11:21:19Z","timestamp":1644405679000},"page":"105661","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Identification of novel antiplatelet agents by targeting Glycoprotein VI: A combined virtual screening study"],"prefix":"10.1016","volume":"121","author":[{"given":"Simla","family":"Ol\u011fa\u00e7","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdurrahman","family":"Ol\u011fa\u00e7","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0130dil","family":"Yenicesu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yesim","family":"Ozkan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bioorg.2022.105661_b0005","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1146\/annurev.pharmtox.46.120604.141207","article-title":"Regulation of Platelet Functions by P2 receptors","volume":"46","author":"Gachet","year":"2006","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.bioorg.2022.105661_b0010","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1111\/j.1538-7836.2009.03586.x","article-title":"Platelet functions beyond hemostasis","volume":"7","author":"Smyth","year":"2009","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.bioorg.2022.105661_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0049-3848(99)00015-8","article-title":"Platelet dense granules: Structure, function and implications for haemostasis","volume":"95","author":"McNicol","year":"1999","journal-title":"Thromb. Res."},{"key":"10.1016\/j.bioorg.2022.105661_b0020","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1055\/s-2005-916671","article-title":"Platelets\u202f: Physiology and Biochemistry","volume":"31","author":"Jurk","year":"2005","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.bioorg.2022.105661_b0025","first-page":"33","article-title":"Newer agents in antiplatelet therapy: a review","volume":"3","author":"Yeung","year":"2012","journal-title":"J. Blood Med."},{"issue":"11","key":"10.1016\/j.bioorg.2022.105661_b0030","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.tips.2012.07.004","article-title":"Platelet GPVI: a target for antithrombotic therapy?!","volume":"33","author":"D\u00fctting","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bioorg.2022.105661_b0035","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1182\/blood-2005-06-2406","article-title":"Laminin stimulates spreading of platelets through integrin alpha6beta1\u2013dependent activation of GPVI","volume":"107","author":"Inoue","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bioorg.2022.105661_b0040","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1042\/bj3390413","article-title":"Monomeric (glycine-proline-hydroxyproline)10 repeat sequence is a partial agonist of the platelet collagen receptor glycoprotein VI","volume":"339","author":"Asselin","year":"1999","journal-title":"Biochem. J."},{"key":"10.1016\/j.bioorg.2022.105661_b0045","doi-asserted-by":"crossref","first-page":"39452","DOI":"10.1074\/jbc.M300199200","article-title":"Convulxin Binds to Native, Human Glycoprotein Ibalpha*","volume":"278","author":"Kanaji","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2022.105661_b0050","doi-asserted-by":"crossref","first-page":"23998","DOI":"10.1074\/jbc.M003803200","article-title":"Expression and Function of the Mouse Collagen Receptor Glycoprotein VI Is Strictly Dependent on Its Association with the FcR gamma Chain*","volume":"275","author":"Nieswandt","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2022.105661_b0055","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1182\/blood-2015-04-641654","article-title":"Fibrin activates GPVI in human and mouse platelets","volume":"126","author":"Alshehri","year":"2015","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.bioorg.2022.105661_b0060","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.thromres.2005.08.001","article-title":"GPVI-deficient mice lack collagen responses and are protected against experimentally induced pulmonary thromboembolism","volume":"118","author":"Lockyer","year":"2006","journal-title":"Thromb. Res."},{"key":"10.1016\/j.bioorg.2022.105661_b0065","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1111\/j.1538-7836.2011.04328.x","article-title":"Genetic and antibody-induced glycoprotein VI deficiency equally protects mice from mechanically and FeCl 3-induced thrombosis","volume":"9","author":"Bender","year":"2011","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.bioorg.2022.105661_b0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071193","article-title":"The GPVI - Fc Fusion Protein Revacept Reduces Thrombus Formation and Improves Vascular Dysfunction in Atherosclerosis without Any Impact on Bleeding Times","volume":"8","author":"Ungerer","year":"2013","journal-title":"PLoS One."},{"key":"10.1016\/j.bioorg.2022.105661_b0075","first-page":"1","article-title":"Overcoming challenges in developing small molecule inhibitors for GPVI and CLEC-2","author":"Damaskinaki","year":"2021","journal-title":"Platelets"},{"issue":"21","key":"10.1016\/j.bioorg.2022.105661_b0080","doi-asserted-by":"crossref","first-page":"12213","DOI":"10.1021\/acs.jmedchem.0c00262","article-title":"Progress toward a Glycoprotein VI Modulator for the Treatment of Thrombosis","volume":"63","author":"Foster","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105661_b0085","unstructured":"Internet: Poppert, H. Revacept in Symptomatic Carotid Stenosis (Revacept\/CS\/02). ClinicalTrials. URL: https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01645306, Last access date: 12.07.2021."},{"issue":"17","key":"10.1016\/j.bioorg.2022.105661_b0090","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1161\/CIRCULATIONAHA.110.980623","article-title":"Novel Antiplatelet Drug Revacept (Dimeric Glycoprotein VI-Fc) Specifically and Efficiently Inhibited Collagen-Induced Platelet Aggregation Without Affecting General Hemostasis in Humans","volume":"123","author":"Ungerer","year":"2011","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.bioorg.2022.105661_b0095","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1177\/1747493016654532","article-title":"Beyond antiplatelets: The role of glycoprotein VI in ischemic stroke","volume":"11","author":"Induruwa","year":"2016","journal-title":"Int. J. Stroke."},{"issue":"2","key":"10.1016\/j.bioorg.2022.105661_b0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1096\/fj.03-0464fje","article-title":"Soluble glycoprotein VI dimer inhibits platelet adhesion and aggregation to the injured vessel wall in vivo","volume":"18","author":"Massberg","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.bioorg.2022.105661_b0105","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1182\/blood.2020009440","article-title":"Structural characterization of a novel GPVI-nanobody complex reveals a biologically active domain-swapped GPVI dimer","volume":"137","author":"Slater","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.bioorg.2022.105661_b0110","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0140-6736(97)01187-2","article-title":"Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)","volume":"349","author":"Pitt","year":"1997","journal-title":"The Lancet."},{"issue":"6","key":"10.1016\/j.bioorg.2022.105661_b0115","doi-asserted-by":"crossref","first-page":"e101209","DOI":"10.1371\/journal.pone.0101209","article-title":"Discovery of novel GPVI receptor antagonists by structure-based repurposing","volume":"9","author":"Taylor","year":"2014","journal-title":"PLoS One."},{"issue":"6","key":"10.1016\/j.bioorg.2022.105661_b0120","doi-asserted-by":"crossref","first-page":"e0128744","DOI":"10.1371\/journal.pone.0128744","article-title":"Inhibition of Glycoprotein VI Clustering by Collagen as a Mechanism of Inhibiting Collagen-Induced Platelet Responses: The Example of Losartan","volume":"10","author":"Jiang","year":"2015","journal-title":"PLoS One."},{"issue":"5","key":"10.1016\/j.bioorg.2022.105661_b0125","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1021\/jm901534d","article-title":"Structural basis for platelet antiaggregation by angiotensin II type 1 receptor antagonist losartan (DuP-753) via glycoprotein VI","volume":"53","author":"Ono","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105661_b0130","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1021\/acs.jmedchem.6b01360","article-title":"Novel Glycoprotein VI Antagonists as Antithrombotics: Synthesis, Biological Evaluation, and Molecular Modeling Studies on 2,3- Disubstituted Tetrahydropyrido(3,4 - b)indoles","volume":"60","author":"Bhunia","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105661_b0135","doi-asserted-by":"crossref","unstructured":"Schr\u00f6dinger Release 2017-1: Canvas, Schr\u00f6dinger, LLC, New York, NY, 2017.","DOI":"10.2307\/j.ctvcm4h07.63"},{"key":"10.1016\/j.bioorg.2022.105661_b0140","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jmgm.2010.05.008","article-title":"Analysis and comparison of 2D fingerprints: Insights into database screening performance using eight fingerprint methods","volume":"29","author":"Duan","year":"2010","journal-title":"J. Mol. Graph. Model."},{"issue":"5","key":"10.1016\/j.bioorg.2022.105661_b0145","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1021\/ci100062n","article-title":"Large-scale systematic analysis of 2D fingerprint methods and parameters to improve virtual screening enrichments","volume":"50","author":"Sastry","year":"2010","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bioorg.2022.105661_b0150","doi-asserted-by":"crossref","unstructured":"Schr\u00f6dinger Release 2017-1: LigPrep, Schr\u00f6dinger, LLC, New York, NY, 2017.","DOI":"10.2307\/j.ctvcm4h07.63"},{"issue":"8","key":"10.1016\/j.bioorg.2022.105661_b0155","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10822-009-9268-1","article-title":"Energetic analysis of fragment docking and application to structure-based pharmacophore hypothesis generation","volume":"23","author":"Loving","year":"2009","journal-title":"J. Comput. Aided. Mol. Des."},{"issue":"10","key":"10.1016\/j.bioorg.2022.105661_b0160","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1021\/ci900212v","article-title":"Novel Method for Generating Structure-Based Pharmacophores Using Energetic Analysis","volume":"49","author":"Salam","year":"2009","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bioorg.2022.105661_b0165","doi-asserted-by":"crossref","unstructured":"Schr\u00f6dinger Release 2017-1: Phase, Schr\u00f6dinger, LLC, New York, NY, 2017.","DOI":"10.2307\/j.ctvcm4h07.63"},{"key":"10.1016\/j.bioorg.2022.105661_b0170","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1747-0285.2006.00384.x","article-title":"PHASE: A Novel Approach to Pharmacophore Modeling and 3D Database Searching","volume":"67","author":"Dixon","year":"2006","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bioorg.2022.105661_b0175","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s10822-006-9087-6","article-title":"PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results","volume":"20","author":"Dixon","year":"2006","journal-title":"J. Comput. Aided. Mol. Des."},{"issue":"5","key":"10.1016\/j.bioorg.2022.105661_b0180","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1161\/ATVBAHA.106.138693","article-title":"EXP3179 Inhibits Collagen-Dependent Platelet Activation via Glycoprotein Receptor-VI Independent of AT 1 -Receptor Antagonism Potential Impact on Atherothrombosis","volume":"27","author":"Grothusen","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bioorg.2022.105661_b0185","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1182\/blood-2006-01-010215","article-title":"Structural basis for platelet collagen responses by the immune-type receptor glycoprotein VI","volume":"108","author":"Horii","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bioorg.2022.105661_b0190","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Sastry","year":"2013","journal-title":"J. Comput. Aided. Mol. Des."},{"key":"10.1016\/j.bioorg.2022.105661_b0195","unstructured":"Schr\u00f6dinger Release 2017-1: Protein Preparation Wizard; Epik, Schr\u00f6dinger, LLC, New York, NY, 2017; Impact, Schr\u00f6dinger, LLC, New York, NY; Prime, Schr\u00f6dinger, LLC, New York, NY, 2017."},{"key":"10.1016\/j.bioorg.2022.105661_b0200","doi-asserted-by":"crossref","unstructured":"Schr\u00f6dinger Release 2017-1: Sitemap, Schr\u00f6dinger, LLC, New York, NY, 2017.","DOI":"10.2307\/j.ctvcm4h07.63"},{"issue":"2","key":"10.1016\/j.bioorg.2022.105661_b0205","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1747-0285.2007.00483.x","article-title":"New Method for Fast and Accurate Binding-site Identification and Analysis","volume":"69","author":"Halgren","year":"2007","journal-title":"Chem. Biol. Drug Des."},{"issue":"2","key":"10.1016\/j.bioorg.2022.105661_b0210","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1021\/ci800324m","article-title":"Identifying and Characterizing Binding Sites and Assessing Druggability","volume":"49","author":"Halgren","year":"2009","journal-title":"J. Chem. Inf. Model."},{"issue":"16","key":"10.1016\/j.bioorg.2022.105661_b0215","doi-asserted-by":"crossref","first-page":"10720","DOI":"10.1074\/jbc.M808563200","article-title":"Structural and interaction analysis of glycoprotein VI-binding peptide selected from a phage display library","volume":"284","author":"Kato-Takagaki","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2022.105661_b0220","doi-asserted-by":"crossref","unstructured":"Schr\u00f6dinger Release 2017-1: Glide, Schr\u00f6dinger, LLC, New York, NY, 2017.","DOI":"10.2307\/j.ctvcm4h07.63"},{"key":"10.1016\/j.bioorg.2022.105661_b0225","doi-asserted-by":"crossref","unstructured":"R.A. Friesner, J.L. Banks, R.B. Murphy, T. a. Halgren, J.J. Klicic, D.T. Mainz, M.P. Repasky, E.H. Knoll, M. Shelley, J.K. Perry, D.E. Shaw, P. Francis, P.S. Shenkin, Glide: A New Approach for Rapid, Accurate Docking and Scoring. 1. Method and Assessment of Docking Accuracy, J. Med. Chem. 47 (2004) 1739\u20131749. doi:10.1021\/jm0306430.","DOI":"10.1021\/jm0306430"},{"key":"10.1016\/j.bioorg.2022.105661_b0230","doi-asserted-by":"crossref","unstructured":"T.A. Halgren, R.B. Murphy, R.A. Friesner, H.S. Beard, L.L. Frye, W.T. Pollard, J.L. Banks, Glide: A New Approach for Rapid, Accurate Docking and Scoring. 2. Enrichment Factors in Database Screening, J. Med. Chem. 47 (2004) 1750\u20131759. doi.org\/10.1021\/jm030644s.","DOI":"10.1021\/jm030644s"},{"key":"10.1016\/j.bioorg.2022.105661_b0235","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","article-title":"Extra Precision Glide: Docking and Scoring Incorporating a Model of Hydrophobic Enclosure for Protein\u2212Ligand Complexes","volume":"49","author":"Friesner","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105661_b0240","doi-asserted-by":"crossref","unstructured":"Schr\u00f6dinger Release 2017-1: Maestro, Schr\u00f6dinger, LLC, New York, NY, 2017.","DOI":"10.2307\/j.ctvcm4h07.63"},{"key":"10.1016\/j.bioorg.2022.105661_b0245","unstructured":"The PyMOL Molecular Graphics System, Schr\u00f6dinger, LLC. Version 2.4.1."},{"issue":"1","key":"10.1016\/j.bioorg.2022.105661_b0250","doi-asserted-by":"crossref","first-page":"W530","DOI":"10.1093\/nar\/gkab294","article-title":"PLIP 2021: expanding the scope of the protein\u2013ligand interaction profiler to DNA and RNA","volume":"49","author":"Adasme","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bioorg.2022.105661_b0255","doi-asserted-by":"crossref","first-page":"W443","DOI":"10.1093\/nar\/gkv315","article-title":"PLIP: fully automated protein-ligand interaction profiler","volume":"43","author":"Salentin","year":"2015","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"10.1016\/j.bioorg.2022.105661_b0260","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3109\/09537104.2010.544343","article-title":"Tityus discrepans scorpion venom activates platelets through GPVI and a novel Src-dependent signaling pathway","volume":"22","author":"Braz\u00f3n","year":"2011","journal-title":"Platelets"},{"issue":"43","key":"10.1016\/j.bioorg.2022.105661_b0265","doi-asserted-by":"crossref","first-page":"33427","DOI":"10.1074\/jbc.M001439200","article-title":"Interaction of Linker for Activation of T Cells with Multiple Adapter Proteins in Platelets Activated by the Glycoprotein VI-selective Ligand, Convulxin *","volume":"275","author":"Asazuma","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2022.105661_b0270","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1113\/jphysiol.1963.sp007185","article-title":"The Aggregation of Blood Platelets","volume":"168","author":"Born","year":"1963","journal-title":"J. Physiol."},{"issue":"1-3","key":"10.1016\/j.bioorg.2022.105661_b0275","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"4","key":"10.1016\/j.bioorg.2022.105661_b0280","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead- and drug-like compounds: the rule-of-five revolution","volume":"1","author":"Lipinski","year":"2004","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.bioorg.2022.105661_b0285","first-page":"1","article-title":"Structure-function relationship of the platelet glycoprotein VI (GPVI) receptor: does it matter if it is a dimer or monomer?","volume":"00","author":"Clark","year":"2021","journal-title":"Platelets"},{"key":"10.1016\/j.bioorg.2022.105661_b0290","doi-asserted-by":"crossref","unstructured":"M.M. Jung SM, Tsuji K, Glycoprotein (GP) VI dimer as a major collagen-binding site of native platelets\u00a0: direct evidence obtained with dimeric GPVI- specific Fabs, J. Thromb. Haemost. 7 (2009) 1347\u20131355. 10.1111\/j.1538-7836.2009.03496.x.","DOI":"10.1111\/j.1538-7836.2009.03496.x"},{"issue":"48","key":"10.1016\/j.bioorg.2022.105661_b0295","doi-asserted-by":"crossref","first-page":"46197","DOI":"10.1074\/jbc.M204029200","article-title":"Analysis of the Interaction of Platelet Collagen Receptor Glycoprotein VI (GPVI) with Collagen","volume":"277","author":"Miura","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2022.105661_b0300","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1055\/a-1401-5014","article-title":"Evidence that GPVI is Expressed as a Mixture of Monomers and Dimers, and that the D2 Domain is not Essential for GPVI Activation","volume":"121","author":"Clark","year":"2021","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.bioorg.2022.105661_b0305","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/ATVBAHA.111.243402","article-title":"Better Safe Than Sorry: Glycoprotein VI Dimerization as a Novel Checkpoint and Early Biomarker of Platelet Activation","volume":"32","author":"D\u00fctting","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bioorg.2022.105661_b0310","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/j.1538-7836.2009.03502.x","article-title":"Direct evidence of a native GPVI dimer at the platelet surface","volume":"7","author":"Herr","year":"2009","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.bioorg.2022.105661_b0315","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0008-6363(98)00306-X","article-title":"Collagen-platelet interaction: Gly-Pro-Hyp is uniquely specific for platelet Gp VI and mediates platelet activation by collagen","volume":"41","author":"Knight","year":"1999","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bioorg.2022.105661_b0320","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1042\/bj3060337","article-title":"Integrin alpha 2 beta 1-independent activation of platelets by simple collagen-like peptides: collagen tertiary (triple-helical) and quaternary (polymeric) structures are sufficient alone for alpha 2 beta 1-independent platelet reactivity","volume":"306","author":"Morton","year":"1995","journal-title":"Biochem. J."},{"key":"10.1016\/j.bioorg.2022.105661_b0325","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1182\/blood.V89.4.1235","article-title":"A collagen-like peptide stimulates tyrosine phosphorylation of syk and phospholipase C gamma2 in platelets independent of the integrin alpha2beta1","volume":"89","author":"Asselin","year":"1997","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bioorg.2022.105661_b0330","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1107\/S0907444903021620","article-title":"Structure of the snake-venom toxin convulxin","volume":"60","author":"Batuwangala","year":"2004","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"issue":"2","key":"10.1016\/j.bioorg.2022.105661_b0335","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/09537104.2019.1585526","article-title":"Comparison of the GPVI inhibitors losartan and honokiol","volume":"31","author":"Onselaer","year":"2020","journal-title":"Platelets"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206822000669?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206822000669?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:25:44Z","timestamp":1758615944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206822000669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":67,"alternative-id":["S0045206822000669"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2022.105661","relation":{},"ISSN":["0045-2068"],"issn-type":[{"type":"print","value":"0045-2068"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of novel antiplatelet agents by targeting Glycoprotein VI: A combined virtual screening study","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2022.105661","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105661"}}